Showing results (591-600 of 887) with videos related to

Sort By:
Pageof 89
Journal of Personalized Medicine|August 6, 2021
Quantitative Measurement of Breast Tumors Using Intravoxel Incoherent Motion (IVIM) MR ImagesSi-Wa Chan, Wei-Hsuan Hu, Yen-Chieh Ouyang, et al.
Frontiers in Medicine|July 24, 2023
Investigation of the underuse of adrenaline (epinephrine) and prognosis among patients with anaphylaxis at emergency department admissionYen-Yue Lin, Hsin-An Chang, Yung-Hsi Kao, et al.
Biomedical Engineering Online|September 5, 2022
A full-face mask for protection against respiratory infectionsChen-Hsun Weng, Chia-Lung Kao, Po-Wei Chiu, et al.
Journal of Clinical Immunology|November 18, 2010
CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki diseaseHo-Chang Kuo, Chi-Di Liang, Hong-Ren Yu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 22, 2023
Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitisHsin-Yun Wu, Tung-Hung Su, Chun-Jen Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 26, 2019
Ptosis and macroglossia in a woman with systemic light-chain amyloidosisPo-Jen Hsiao, Ya-Chieh Chang, Yuan-Heng Tsao, et al.
Neuropsychiatric Disease and Treatment|October 25, 2024
Health-Care Utilisation and Costs of Transition from Paliperidone Palmitate 1-Monthly to 3-Monthly Treatment for Schizophrenia: A Real-World, Retrospective, 24-Month Mirror-Image StudyBo-Chieh Chang, Meng-Hsuan Kuo, Chi-Hui Lee, et al.
Cancer|September 18, 2007
Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavityChun-Ta Liao, Hung-Ming Wang, Joseph Tung-Chieh Chang, et al.
Infection and Immunity|July 7, 2011
Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cellsChia-Der Lin, Cheng-Kuo Lai, Yu-Hsin Lin, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2011
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trialJyh-Ming Liou, Chieh-Chang Chen, Mei-Jyh Chen, et al.
Pageof 89